 Drug Interactions
"Drug Interactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The action of a drug that may affect the activity, metabolism, or toxicity of another drug.
| Descriptor ID |
D004347
|
| MeSH Number(s) |
G07.690.812.240 G07.700.680.240
|
| Concept/Terms |
Drug Interactions- Drug Interactions
- Drug Interaction
- Interaction, Drug
- Interactions, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Interactions".
Below are MeSH descriptors whose meaning is more specific than "Drug Interactions".
This graph shows the total number of publications written about "Drug Interactions" by people in this website by year, and whether "Drug Interactions" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 1 | 1 | | 1984 | 0 | 2 | 2 | | 1985 | 0 | 1 | 1 | | 1986 | 0 | 1 | 1 | | 1987 | 0 | 2 | 2 | | 1988 | 0 | 3 | 3 | | 1989 | 0 | 1 | 1 | | 1990 | 0 | 4 | 4 | | 1991 | 0 | 7 | 7 | | 1992 | 0 | 3 | 3 | | 1993 | 0 | 8 | 8 | | 1994 | 0 | 4 | 4 | | 1995 | 0 | 2 | 2 | | 1996 | 0 | 3 | 3 | | 1997 | 0 | 5 | 5 | | 1998 | 0 | 6 | 6 | | 1999 | 0 | 4 | 4 | | 2000 | 0 | 3 | 3 | | 2001 | 1 | 9 | 10 | | 2002 | 0 | 11 | 11 | | 2003 | 0 | 14 | 14 | | 2004 | 0 | 6 | 6 | | 2005 | 0 | 12 | 12 | | 2006 | 0 | 12 | 12 | | 2007 | 0 | 6 | 6 | | 2008 | 0 | 6 | 6 | | 2009 | 0 | 8 | 8 | | 2010 | 1 | 6 | 7 | | 2011 | 0 | 14 | 14 | | 2012 | 0 | 9 | 9 | | 2013 | 2 | 7 | 9 | | 2014 | 0 | 1 | 1 | | 2015 | 0 | 3 | 3 | | 2016 | 0 | 2 | 2 | | 2017 | 0 | 4 | 4 | | 2018 | 0 | 1 | 1 | | 2019 | 0 | 5 | 5 | | 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Interactions" by people in Profiles.
-
Gorska-Ponikowska M, Kuban-Jankowska A, Marino Gammazza A, Daca A, Wierzbicka JM, Zmijewski MA, Luu HH, Wozniak M, Cappello F. The Major Heat Shock Proteins, Hsp70 and Hsp90, in 2-Methoxyestradiol-Mediated Osteosarcoma Cell Death Model. Int J Mol Sci. 2020 Jan 17; 21(2).
-
RamÃrez J, House LK, Karrison TG, Janisch LA, Turcich M, Salgia R, Ratain MJ, Sharma MR. Prolonged Pharmacokinetic Interaction Between Capecitabine and a CYP2C9 Substrate, Celecoxib. J Clin Pharmacol. 2019 12; 59(12):1632-1640.
-
Charlton MR, Gane EJ, Shukla A, Dashtseren B, Duger D, Muljono DH, Payawal DA, Jargalsaikhan G, Purnomo HD, Cua IH, Hasan I, Sollano J, Win KM, Lesmana LA, Salih M, Thi Thu Thuy P, Shankar R, Saraswat VA. International Liver Transplantation Society Asian Consensus on the Management of Hepatitis C Virus Infection in Resource Limited Setting-From Noncirrhotic to Decompensated Disease and After Liver Transplantation. Transplantation. 2019 04; 103(4):733-746.
-
Savona MR, Odenike O, Amrein PC, Steensma DP, DeZern AE, Michaelis LC, Faderl S, Harb W, Kantarjian H, Lowder J, Oganesian A, Azab M, Garcia-Manero G. An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study. Lancet Haematol. 2019 Apr; 6(4):e194-e203.
-
Collins J, Shea K, Parsad S, Plach K, Lee P. The impact of initiating posaconazole on tacrolimus pharmacokinetics in allogeneic stem cell transplantation. J Oncol Pharm Pract. 2020 Jan; 26(1):5-12.
-
Li Y, Yu J, Hu S, Chen Z, Sacchetti M, Sun CC, Yu L. Polymer Nanocoating of Amorphous Drugs for Improving Stability, Dissolution, Powder Flow, and Tabletability: The Case of Chitosan-Coated Indomethacin. Mol Pharm. 2019 03 04; 16(3):1305-1311.
-
Shumaker AC, Bullard HM, Churpek J, Knoebel RW. Posaconazole-digoxin drug-drug interaction mediated by inhibition of P-glycoprotein. J Oncol Pharm Pract. 2019 Oct; 25(7):1758-1761.
-
Qato DM, Alexander GC, Guadamuz JS, Lindau ST. Prescription Medication Use Among Children and Adolescents in the United States. Pediatrics. 2018 09; 142(3).
-
Miyauchi M, Neugebauer NM, Sato T, Ardehali H, Meltzer HY. Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats. J Psychopharmacol. 2017 12; 31(12):1588-1604.
-
Kane-Gill SL, O'Connor MF, Rothschild JM, Selby NM, McLean B, Bonafide CP, Cvach MM, Hu X, Konkani A, Pelter MM, Winters BD. Technologic Distractions (Part 1): Summary of Approaches to Manage Alert Quantity With Intent to Reduce Alert Fatigue and Suggestions for Alert Fatigue Metrics. Crit Care Med. 2017 Sep; 45(9):1481-1488.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|